Products in the News

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Share Like Tweet Add Email

Boston Scientific Corp.

One Boston Scientific Place, Natick, MA, 01760, USA

Original Press Release

Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs

Press release date: August 19, 2014

Companies Reach Agreement to Develop a New and Differentiated FFR Guidewire and Next Generation Boston Scientific Rotablator(TM) RotaWire(TM)

MARLBOROUGH, Mass. and NAGOYA, Japan, -- Boston Scientific Corporation (NYSE: BSX) and ASAHI INTECC (Securities Code 7747, Second Section, Tokyo and Nagoya Stock Exchange) have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire.  The joint project focuses on creating a device intended to improve handling compared to existing FFR wires.

The FFR market is an emerging field in interventional cardiology that exceeds $250 million worldwide and is experiencing a double digit growth rate.  FFR guided percutaneous coronary intervention (PCI) is cost effective and also reduces one-year major adverse cardiac events (MACE) rates.  The jointly developed FFR wire will be designed for use with the Boston Scientific POLARIS(TM) Multi-Modality Imaging System.

The companies have also agreed to collaborate on key enhancements to the Boston Scientific RotaWire(TM) Atherectomy Guidewire.  ASAHI INTECC will provide components for the new RotaWire which is designed by Boston Scientific to provide improved control and handling.  The RotaWire is a unique 0.009" wire that is used within the Boston Scientific market leading Rotablator(TM) Rotational Atherectomy System to treat calcified lesions in coronary arteries. 

The introduction of the components manufactured by ASAHI INTECC to advance the RotaWire Atherectomy Guidewire is further evidence of the Boston Scientific commitment to improving products used in the treatment of complex coronary disease.

"We expect our collaboration with ASAHI INTECC to help improve care for patients with coronary artery disease and strengthen our interventional cardiology portfolio," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific.  "The ASAHI INTECC expertise in guidewire technology is unparalleled.  By leveraging the strengths of our technologies, we have the opportunity to create truly differentiated products."

"Boston Scientific has advanced sensor and atherectomy technologies.  By combining these technologies with our expertise in wires and components, we believe the manipulability of these products will improve dramatically," said Masahiko Miyata, president and chief executive officer, ASAHI INTECC.  "Through our collaboration with Boston Scientific, we are confident that we will be able to help improve outcomes for patients."

ASAHI INTECC specializes in wire drawing, wire forming, torque transmission, and coating processes for percutaneous transluminal coronary angiography (PTCA) guidewires. 

Boston Scientific anticipates commercializing both specialty wires in 2015.

About ASAHI INTECC
ASAHI INTECC develops, manufactures and sells original brand guidewires and catheters used in less invasive cardiovascular, peripheral vascular, abdominal vascular and neurovascular procedures, as well as original equipment manufacturer (OEM) products and medical components.  The original brand PTCA guidewires have top market share in Japan.  In the industrial device field, ASAHI INTECC supplies ultrafine stainless wire rope used in a wide range of applications such as office automation equipment and automobiles.  ASAHI INTECC identifies its mission as continuing to provide the world market with its "Only One" technology and "Number One" product for less invasive procedures to improve patients' quality of life.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACT:
Media: Ryan Davenport
Global Media Relations
Boston Scientific Corporation
763-494-2664 (office)
media@bsci.com

ASAHI INTECC: Yoshinori Terai
ASAHI INTECC USA Inc. 
949-756-8252 (office)
customersupport@asahi-intecc.com

Share Like Tweet Add Email

LIKE THIS ARTICLE? DON’T MISS OUT ON OTHERS! Get Thomasnet’s industry newsletter now

Comments

comments powered by Disqus